The Company, through its subsidiaries, distributes pharmaceutical products, as well as health-and-beauty/other products, entertainment products, food/non-perishable products and office/electronic products.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
- Return on Equity = 16.9%
- Currently trading at 1.2x FCF!!!!
- PEG = 1.7
- Price-to-Book = 1.8
- Extremely low debt (debt to income = 2%)
- With 7% growth and a current yearly EPS of $3.46 I calculate this stocks value at $75
Mexico is an emerging market poised to benefit from immigration reform in the U.S. SABA will capitalize on the growth and and advancement of Mexico.